Le Lézard
Classified in: Science and technology
Subjects: Product/Service, Survey

Luminati Networks: 54% of IT decision makers admit to data collection shortcomings


Luminati Networks, a leading data collection provider dedicated to enabling businesses to view the internet with complete transparency, has announced research findings that highlight the increasing need for large-scale data collection.

Over half (54%) of IT decision makers that took part in an online data collection research panel conducted by the leading research firm Frost & Sullivan and commissioned by Luminati expressed a need for larger-scale data collection as appetite for data continues to grow. Other data collection challenges include a lack of visibility into regional insights (24%) and being blocked from websites when trying to access publicly available data (22%).

Of the 128 IT decision makers from industries including retail, financial services, travel, security, brand protection and marketing, almost half said they use data collection for business critical operations such as market research (49%), collection of competitive public data (44%) and price comparison (7%). However, nearly two-thirds (65%) of businesses are yet to deploy enterprise solutions for collecting data at scale.

"These findings highlight that brands from a wide range of sectors are using data collection for market research and gaining strategic insights, but capacity issues and the inability to unlock geographical-based online data, are still causing roadblocks across the board," said Or Lenchner, CEO of Luminati Networks. "To benefit from the valuable insights that data can provide, brands need to be working with partners who can deliver the capability to collect the right data, in the required volumes, fast. Failure to do this will see brands fall behind in their respective sectors and that's why they must act now."

Luminati has been a pioneer of the data collection domain since its inception and continues to lead the market with its proprietary technology and innovation. Luminati provides its thousands of customers, which include market-leaders from Fortune 500 companies, and industry leaders across multiple sectors, the data they require to succeed through its industry-leading IP proxy network and advanced data collection tools.

About Luminati Networks

With Luminati, businesses have the tools to collect data at scale and gain a real and accurate perspective of how customers are interacting with their brand and with their competitors ? openly without being blocked or served misleading information. Ethical standards are at the heart of Luminati's DNA and the company is proud to work alongside its customers to collect data through an ethical-by-design approach. To find out more about Luminati Networks' extensive data collection platform and how it can benefit your business, visit their website here.


These press releases may also interest you

at 07:10
The "Protocol Analyzer - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering. Global Protocol Analyzer Market accounted for $938.36 million in 2019 and is expected to reach $1,235.64 million by 2027, growing...

at 07:08
The COVID-19 crisis has sent cyber attacks soaring 400% according to the FBI's Internet Crimes Complaint Center (IC3). At the same time, there is a severe shortage of qualified professionals to safeguard data from hackers. In response to a booming...

at 07:05
PDI (www.pdisoftware.com), a global provider of enterprise software solutions to the convenience retail, wholesale petroleum and logistics industries, announced it is extending its business relationship with the UK-based gasoline and convenience...

at 07:05
Gilead Sciences, Inc. today announced 48-week data from the BRAAVE 2020 study, a Phase 3 clinical trial evaluating the safety and efficacy of switching to Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg tablets,...

at 07:05
In the face of concerns related to COVID-19, geopolitical tensions, the upcoming US presidential election, and a potential hard Brexit, global VC investment actually rose for the second straight quarter ? reaching $73.2 billion in Q3'20, according to...

at 07:05
AVROBIO, Inc. , a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today announced the appointment of Gail M. Farfel, Ph.D., to its Board of Directors. Dr. Farfel brings more than 25 years...



News published on 24 september 2020 at 12:40 and distributed by: